28 Apr 2025 Research & Development Spotlight Series, Episode 9 Investors | R&D Spotlights Series | Therapeutics
28 Apr 2025 Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting Investors | Therapeutics
28 Apr 2025 Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting Investors | Therapeutics
31 Mar 2025 Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives Investors
26 Mar 2025 Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting Investors | Therapeutics